Case number 2016-1060
Endo Pharmaceuticals Inc. v. Roxane Laboratories, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 29, 2018 | 8 | ORDER filed. The dismissal of Grünenthal’s appeals is vacated and the appeals are reinstated. The appeals are remanded to the district court for the limited purpose of its consideration of Grünenthal’s motion for vacatur. The court retains jurisdiction so that any of the parties may seek appellate review by notifying the Clerk of the Court within thirty days of entry of the district court’s decision on remand. Grünenthal’s appeals are held in abeyance pending the resolution of its motion for vacatur by the district court. Grünenthal’s conditional motions [528191-2], [531502-2] and Kashiv’s motion [526538-2] are denied. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [532702] [15-2021, 15-2022, 15-2023, 15-2024, 15-2025, 15-2026, 15-2028, 15-2031, 15-2033, 15-2034, 15-2035, 15-2041, 15-2042, 15-2046, 15-2047, 15-2049, 15-2059, 15-2060, 16-1025, 16-1060, 16-1117, 16-1118] [JAB] [Entered: 06/29/2018 09:37 AM] (3) |
| Jun 29, 2018 | 9 | This entry was made in error and has been removed from the docket. Mandate issued to the United States District Court for the Southern District of New York. Service as of this date by the Clerk of Court. [532719] [15-2022, 15-2023, 15-2025, 15-2028, 15-2033, 15-2034, 15-2035, 15-2041, 15-2042, 15-2046, 15-2047, 15-2049, 15-2059, 15-2060, 16-1025, 16-1060, 16-1117, 16-1118]--[Edited 06/29/2018 by JAB to delete entry] [JAB] [Entered: 06/29/2018 10:18 AM] (0) |
| Jun 29, 2018 | 10 | Mandate issued to the United States District Court for the Southern District of New York. Service as of this date by the Clerk of Court. [532775] [JAB] [Entered: 06/29/2018 11:24 AM] (1) |
| May 16, 2018 | 7 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. The motions [498233-2], [498247-2], [499990-2], and [506995-2] are granted; Appeal Nos. 15-2022, 15-2023, 15-2025, 15-2028, 15-2033, 15-2034, 15-2035, 15-2041, 15-2042, 15-2047, 15-2049, 15-2059, 15-2060, and 16-1118 are voluntarily dismissed. Appeal Nos. 15-2021, 15-2024, 15-2026, and 15-2031 are dismissed. (Nonprecedential Opinion). (For the Court: Moore, Circuit Judge; Bryson, Circuit Judge and Hughes, Circuit Judge). [522062] [15-2021, 15-2022, 15-2023, 15-2024, 15-2025, 15-2026, 15-2028, 15-2031, 15-2033, 15-2034, 15-2035, 15-2041, 15-2042, 15-2046, 15-2047, 15-2049, 15-2059, 15-2060, 16-1025, 16-1060, 16-1117, 16-1118] Vacated-in-part pursuant to the court's order. See Doc. No. [8]. [JAB] [Entered: 05/16/2018 09:51 AM] (28) |
| Aug 4, 2016 | 5 | CORRECTED ORDER: correcting order [356104-2]. reason(s): correcting parties' appellate designations; 2016-1060, -1118 are added; subparagr. 3). Service as of this date by Clerk of Court. [356237] [16-1025, 16-1117, 15-2022, 15-2023, 15-2024, 15-2025, 15-2026, 15-2028, 15-2031, 15-2033, 15-2034, 15-2035, 15-2041, 15-2042, 15-2046, 15-2047, 15-2049, 15-2059, 15-2060, 16-1060, 16-1118] [AT] [Entered: 08/04/2016 02:55 PM] (3) |
| Jul 15, 2016 | 4 | Amended Notice of Appeal for Endo Pharmaceuticals Inc. Service: 07/18/2016 by email. [351863] [SJ] [Entered: 07/19/2016 10:01 AM] (36) |
| Oct 13, 2015 | 1 | Appeal docketed. Received: 10/01/2015. [279764]. [SJ] [Entered: 10/13/2015 11:43 AM] (209) |
| Oct 13, 2015 | 2 | ORDER deactivating appeal. Service as of this date by Clerk of Court. [279777] [SJ] [Entered: 10/13/2015 11:57 AM] (2) |
| Oct 13, 2015 | 3 | Note to file: The following cases are associated:15-2021 (lead) with 16-1060. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [279780] [15-2021, 16-1060] [SJ] [Entered: 10/13/2015 12:01 PM] (0) |
